Titlebook: Metastatic Bone Disease; Fundamental and Clin Ingo J. Diel,M. Kaufmann,G. Bastert Conference proceedings 1994 Springer-Verlag Berlin Heidel

過于平凡

財主

思鄉(xiāng)病

T. J. Powles,A. H. G. Paterson,J. A. Kanisral critical ‘design parameters’ for the creation of effective small molecule radiopharmaceuticals. More specifically, we will discuss an eclectic set of physicochemical and pharmacological properties, guidelines, tolerances, and ‘rules of thumb’ that—when considered together—can assist in the ident

分離

外觀

Morphological Findings in Bone Metastasis, Tumorosteopathy and Antiosteolytic Therapy, no longer possible. Osseous metastases are therefore generally considered a sign of prognostic deterioration of the malignant disease, although cases with osseous metastases alone are associated with longer survival times than those with extraosseous metastases (Wander 1986). Bone metastases are no

狂怒

Diagnosis of Skeletal Metastases and Assessment of Response to Treatment,) the degree and site of dissemination; (c) the presence of any complications — hypercalcaemia, impending fracture, pathological fracture, spinal instability or neural compression; (d) soft-tissue involvement; and (e) the vascularity of the lesion.

Oligarchy

祖?zhèn)?/a>

CYN

M. J. Seibel,I. Lambrinoudaki,A. Zipfs an attempt to describe the clinical radiobiology of complications arising in different organs after radiotherapy of cancer patients. Since by their very natur978-3-642-83418-9978-3-642-83416-5Series ISSN 0942-5373 Series E-ISSN 2197-4187

變形詞

https://doi.org/10.1007/978-3-642-78596-2Bone Metastases; Diagnose und Behandlung; Diagnosis and Treatment; Knochemetastasen; Oncology; Onkologie;